In addition to these methods, drug induction experiments using glucose transporter inhibitors, such as BAY-876 and KL-11743, have demonstrated the ability to induce disulfidptosis in SLC7A11-overexpressing cancer cells. Here, SLC7A11 is linked to cancer.